Drug intelligence / Profile preview

tiliroside

Development stage
Preclinical
Lead developer
Clarins
Modality
Small Molecules
Administration
Oral (in Dietary Plants And Supplements), Unknown (no Clinical Pharmaceutical Route Established)
01

Overview

Tiliroside is a natural **glycosidic flavonoid** primarily found in several medicinal and dietary plants, such as linden, rose hip, and strawberry. It is chemically classified as a kaempferol glycoside and exhibits a range of bioactivities. Tiliroside displays **anti-inflammatory, antioxidant, antidiabetic, antihyperlipidemic, anticarcinogenic, and hepatoprotective effects**. Its mechanisms include: inhibition of the MAPK/JNK and MAPK/p38 signaling pathways (leading to downregulation of iNOS and COX-2 and decreased NO production), noncompetitive inhibition of α-amylase (relevant for antidiabetic properties), activation of the KEAP1/NRF2 pathway (protecting against oxidative stress and liver injury), and inhibition of aldose reductase[1][3][6][7][11][12][16]. Tiliroside has shown anti-obesity effects via activation of adiponectin signaling and enhancement of fatty acid oxidation in preclinical models, and exhibits cytotoxic activity against certain cancer cell lines[6][11]. It is a plant-derived compound and not a pharmaceutical drug.

Brand names
RONACARE TILIROSIDE
Other names
trans-tilirosidetribulosidekaempferol 3-O-β-D-glucopyranoside-6-p-coumaroyl ester6''-O-trans-p-coumaroylastragalinkaempferol-3-(p-coumaryl)glucoside
02

Targets

PFOR (Pyruvate:ferredoxin oxidoreductase)AMY (Pancreatic alpha-amylase)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NOS2 (Nitric Oxide Synthase 2)AR (Adrenergic receptors)ALDO (Fructose-bisphosphate aldolase A)

Beyond the preview

Go deeper on tiliroside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tiliroside.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call